Clinical Trials
Moderna’s COVID-19 Vaccine Soon to Enter Phase 3 Trials as Phase 1 Shows Positive Results
Moderna, an American biotech company announced on July 14 that its COVID-19 vaccine candidate is finally going to enter the final phase on July...
Drug Research
CEPI expands partnership with Clover to rapidly advance development and manufacture of COVID-19 vaccine candidate
CEPI, the Coalition for Epidemic Preparedness Innovations, announced the expansion of its partnership with Sichuan Clover Biopharmaceuticals, Inc to rapidly advance the development and...
Press Releases
BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns
BD, a leading global medical technology company announced the formation of a strategic, public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA),...
Clinical Trials
ACTC, Eisai & Biogen announce initiation of new phase III clinical study of BAN2401 for preclinical Alzheimer’s disease
The Alzheimer's Clinical Trials Consortium , Eisai Co., Ltd and Biogen Inc announced that a new phase III clinical study (AHEAD 3-45) of BAN2401,...
News
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
Roche and Blueprint Medicines Corporation announced the signing of a licensing and collaboration agreement providing exclusive rights to Roche for global co-development and commercialisation...
Press Releases
Cipla receives final USFDA approval for generic version of Shire’s Firazyr
Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the United States...
Press Releases
Merck Opens its Largest M Lab Collaboration Center in Shanghai
Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.
“With the booming...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read